Vaccination Programmes

The European Commission has approved a fifth contract with the European pharmaceutical company CureVac, which provides for the initial purchase of 225 million doses on behalf of all EU Member States, plus an option to request up to a further 180 million doses, to be supplied once a vaccine has proven to be safe and…

Commission Signs Vaccine Contract with Sanofi-GSK

On Friday, a second contract with a pharmaceutical company entered into force following the contact’s formal signature between Sanofi-GSK and the Commission.  The contract will allow all EU Member States to purchase up to 300 million doses of the Sanofi-GSK vaccine. Moreover, Member States may donate reserved doses to lower- and middle-income countries. Sanofi and GSK…

COVID-19 vaccine

The European Commission says it has concluded exploratory talks with CureVac to purchase a potential vaccine against COVID-19.  This is following the positive steps with Sanofi-GSK on 31 July and Johnson and Johnson on 13 August and the signature of an Advance Purchase Agreement with AstraZeneca on 14 August. The envisaged contract with CureVac would…

Beating Cancer

Europe’s Beating Cancer Plan continues to disregard harm reduction tools, such as e-cigarettes, which, it is claimed, potentially meet the Commission’s objectives of eradicating smoking-related cancer.  That is one of the messages to emerge from public consultations on the plan. Another message is that the EU should not overlook the best practices on harm reduction…

Commission bid to ensure supply of personal protective equipment for the EU proves successful

The joint procurement of personal protective equipment launched by the European Commission to address the coronavirus crisis has proven successful. Producers made offers covering and in some cases even exceeding the quantities requested by the Member States that take part in the procurement, for every single item requested. The joint procurement covers masks type 2…